Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Int J Gynecol Cancer. 2013 May;23(4):615–621. doi: 10.1097/IGC.0b013e31828b4eb5

Table 3.

Disease-free and overall survival by ribonucleotide reductase expression

Group 3-year disease-free survival* 3-year overall survival*
M1
   0–1+ 54% (CI: 38% — 67%) 60% (CI: 40% — 75%)
   2–3+ 57% (CI: 08% — 89%) 100% (CI: N/A)
 P value 0.38 0.11
M2
   0–2+ 38% (CI: 10% — 66%) 47% (CI: 15% — 74%)
   3+ 57% (CI: 38% — 72%) 66% (CI: 40% — 83%)
 P value 0.19 0.07
M2b
   0–1+ 62% (CI: 38% — 79%) 61% (CI: 36% — 78%)
   2–3+ 49% (CI: 27% — 67%) 62% (CI: 27% — 84%)
 P value 0.69 0.16
*

CI denotes 95% confidence interval. N/A: not applicable.